|
Market Closed -
Nasdaq
16:00:00 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 266.11 USD | +0.61% |
|
+12.24% | -33.08% |
| 09-04 | Alnylam's Zilebesiran Sees Commercial Opportunity From Baxfendy Launch, Oppenheimer Says | MT |
| 08-31 | Alnylam's Latest Data Strengthen Outlook for Nucresiran, TRITON-CM, Oppenheimer Says | MT |
| Market Cap | 35.61B 30.64B 28.83B 26.33B 49.26B 3,362B 49.4B 341B 132B 1,725B 134B 131B 5,557B | P/E 2026 * |
40.1x | P/E 2027 * | 28x |
|---|---|---|---|---|---|
| Enterprise Value | 33.03B 28.43B 26.74B 24.43B 45.7B 3,119B 45.83B 316B 123B 1,600B 124B 121B 5,155B | EV / Sales 2026 * |
6.02x | EV / Sales 2027 * | 4.49x |
| Free-Float |
99.82% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ALNY | Delayed | |
CBOE
| ALNY | Real-time | |
|
Tradegate
| DUL | Real-time | |
|
Berne S.E.
| DUL | End-of-day quote | |
|
London S.E.
| 0HD2 | Delayed | |
|
Deutsche Boerse AG
| DUL | Delayed | |
|
Boerse Muenchen
| DUL | Real-time | |
|
Mexican S.E.
| ALNY * | End-of-day quote | |
|
Börse Stuttgart
| DUL | Delayed | |
|
Xetra
| DUL | End-of-day quote | |
|
Borsa Italiana
| 1ALNY | End-of-day quote |
Last Transcript : Alnylam Pharmaceuticals, Inc.
| 1 day | +0.61% | ||
| 1 week | +12.24% | ||
| Current month | +10.56% | ||
| 1 month | +16.35% | ||
| 3 months | -12.19% | ||
| 6 months | -16.97% | ||
| Current year | -33.08% |
| 1 week | 233.33 |  | 271.19 |
| 1 month | 210.49 | | 271.19 |
| Current year | 197.81 | | 427.05 |
| 1 year | 197.81 | | 495.55 |
| 3 years | 141.98 | | 495.55 |
| 5 years | 117.58 | | 495.55 |
| 10 years | 31.38 | | 495.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 63 | 2021-12-31 | |
Jeffrey Poulton
DFI | Director of Finance/CFO | 58 | 2019-08-12 |
| Chief Tech/Sci/R&D Officer | - | 2023-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Dennis Ausiello
BRD | Director/Board Member | 80 | 2012-04-22 |
Amy Schulman
CHM | Chairman | 65 | 2023-01-04 |
David Pyott
BRD | Director/Board Member | 72 | 2015-12-17 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/1/26 | Exercice | Director | 11,490 | 0.0086% | ||
| 6/1/26 | Free | Director | 4,393 | 0.0033% | ||
| 5/20/26 | Free | Director | 2,112 | 0.0016% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.61% | +12.24% | -41.13% | +32.83% | 35.61B | |
| -0.88% | -2.15% | +58.05% | +105.91% | 1,024B | |
| -1.15% | +2.68% | +54.25% | +71.29% | 663B | |
| -1.44% | +0.38% | +20.65% | +75.54% | 453B | |
| +0.14% | -0.47% | +30.20% | +40.61% | 352B | |
| -1.33% | +4.72% | +24.62% | +47.60% | 304B | |
| -1.15% | +0.30% | -0.69% | +11.83% | 252B | |
| -1.55% | +1.11% | +54.15% | +72.13% | 236B | |
| -0.88% | +1.15% | -14.60% | -54.84% | 206B | |
| -0.15% | +3.65% | +31.24% | +100.90% | 187B | |
| Average | -0.78% | +2.21% | +21.67% | +50.38% | 371.4B | |
| Weighted average by Cap. | -0.95% | +0.66% | +36.87% | +66.67% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.49B 4.73B 4.45B 4.06B 7.6B 518B 7.62B 52.53B 20.38B 266B 20.62B 20.17B 857B | 6.94B 5.97B 5.62B 5.13B 9.6B 655B 9.63B 66.4B 25.77B 336B 26.06B 25.5B 1,083B |
| Net income | 915M 787M 741M 677M 1.27B 86.38B 1.27B 8.75B 3.4B 44.32B 3.44B 3.36B 143B | 1.3B 1.12B 1.06B 965M 1.8B 123B 1.81B 12.48B 4.84B 63.17B 4.9B 4.79B 204B |
| Net Debt | -2.57B -2.22B -2.08B -1.9B -3.56B -243B -3.57B -24.63B -9.56B -125B -9.67B -9.46B -402B | -4.44B -3.82B -3.59B -3.28B -6.14B -419B -6.15B -42.43B -16.47B -215B -16.66B -16.29B -692B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-04 | US$266.11 | +0.61% | 1,431,221 |
| 26-09-03 | US$264.50 | -1.08% | 1,710,078 |
| 26-09-02 | US$267.40 | +8.65% | 3,286,329 |
| 26-09-01 | US$246.11 | +2.25% | 1,941,271 |
| 26-08-31 | US$240.69 | +1.51% | 1,636,349 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ALNY Stock
Select your edition
All financial news and data tailored to specific country editions
